A synthesis of single-cell, multi-tissue, and biobank data argues that somatic mitochondrial DNA mutations, amplified by clonal expansion within individual cells, accumulate in a quantifiable, tissue-specific pattern that tracks chronological and biological age. Dividing tissues acquire pervasive point mutations through stem-cell clonal expansion, while post-mitotic tissues accumulate large-scale deletions, both eventually crossing a threshold that produces respiratory-deficient cells. Heteroplasmy burden has been linked to mortality and organ-specific disease, positioning it as a candidate biomarker of biological age alongside epigenetic clocks.
Key Points
- Dividing tissues accumulate point mutations via stem-cell clonal expansion
- Post-mitotic tissues harbor clonally expanded large-scale mtDNA deletions
- Heteroplasmy burden correlates with mortality and organ-specific disease
Longevity Analysis
Energy production failure is not uniform across the body; it is mosaic, cell by cell, and each tissue follows its own trajectory. That distinction reframes how mitochondrial health should be measured and interpreted — a whole-body metabolic marker can appear normal while specific organs are already carrying a heavy load of respiratory-deficient cells. The downstream consequences run through innate immune activation and cellular senescence, meaning mitochondrial mutation burden feeds directly into the inflammatory signaling that shapes late-life disease risk. Single-molecule sequencing now makes this load readable, which moves the conversation from theoretical decline toward measurable, organ-level surveillance.
Original published by Wiley Aging Cell, by Renin Chang, Andy P. Tsai, Boyang Wang, Kuan‐Hao Tsui, Cheng‐Yoong Pang, Chia‐Jung Li .